Department of Nephrology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Chinese PLA Institute of Nephrology, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Chronic Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing 100853, China.
Department of Nephrology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Chinese PLA Institute of Nephrology, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Chronic Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing 100853, China.
Biochim Biophys Acta Mol Basis Dis. 2024 Jun;1870(5):167184. doi: 10.1016/j.bbadis.2024.167184. Epub 2024 Apr 20.
Acute kidney injury (AKI) can cause distal cardiac dysfunction; however, the underlying mechanism is unknown. Oxidative stress is proved prominent in AKI-induced cardiac dysfunction, and a possible bridge role of oxidative-stress products in cardio-renal interaction has been reported. Therefore, this study aimed to investigate the critical role of circulating reactive oxygen species (ROS) in mediating cardiac dysfunction after bilateral renal ischemia-reperfusion injury (IRI). We observed the diastolic dysfunction in the mice following renal IRI, accompanied by reduced ATP levels, oxidative stress, and branched-chain amino acids (BCAA) accumulation in the heart. Notably, ROS levels showed a sequential increase in the kidneys, circulation, and heart. Treatment with tempol, an ROS scavenger, significantly restored cardiac diastolic function in the renal IRI mice, corroborating the bridge role of circulating ROS. Accumulating evidence has identified oxidative stress as upstream of Mst1/Hippo in cardiac injury, which could regulate the expression of downstream genes related to mitochondrial quality control, leading to lower ATP, higher ROS and metabolic disorder. To verify this, we examined the activation of the Mst1/Hippo pathway in the heart of renal IRI mice, which was alleviated by tempol treatment as well. In vitro, analysis revealed that Mst1-knockdown cardiomyocytes could be activated by hydrogen peroxide (HO). Analysis of Mst1-overexpression cardiomyocytes confirmed the critical role of the Mst1/Hippo pathway in oxidative stress and BCAA dysmetabolism. Therefore, our results indicated that circulating ROS following renal IRI activates the Mst1/Hippo pathway of myocardium, leading to cardiac oxidative stress and diastolic dysfunction. This finding provides new insights for the clinical exploration of improved treatment options for cardiorenal syndrome.
急性肾损伤 (AKI) 可导致心脏远隔部位功能障碍;然而,其潜在机制尚不清楚。氧化应激在 AKI 诱导的心脏功能障碍中被证明很突出,并且氧化应激产物在心脏-肾脏相互作用中可能起到桥梁作用。因此,本研究旨在探讨循环活性氧 (ROS) 在介导双侧肾缺血再灌注损伤 (IRI) 后心脏功能障碍中的关键作用。我们观察到肾 IRI 后小鼠出现舒张功能障碍,伴有心脏中 ATP 水平降低、氧化应激和支链氨基酸 (BCAA) 积累。值得注意的是,ROS 水平在肾脏、循环和心脏中呈顺序增加。ROS 清除剂 tempol 的治疗显著恢复了肾 IRI 小鼠的心脏舒张功能,这证实了循环 ROS 的桥梁作用。越来越多的证据表明氧化应激是心脏损伤中 Mst1/Hippo 的上游事件,它可以调节与线粒体质量控制相关的下游基因的表达,导致 ATP 降低、ROS 升高和代谢紊乱。为了验证这一点,我们检查了肾 IRI 小鼠心脏中 Mst1/Hippo 通路的激活情况,tempol 治疗也缓解了这种激活。体外分析表明,过氧化氢 (HO) 可以激活 Mst1 敲低的心肌细胞。Mst1 过表达心肌细胞的分析证实了 Mst1/Hippo 通路在氧化应激和 BCAA 代谢紊乱中的关键作用。因此,我们的结果表明,肾 IRI 后循环 ROS 激活心肌的 Mst1/Hippo 通路,导致心脏氧化应激和舒张功能障碍。这一发现为心脏-肾脏综合征的临床治疗探索提供了新的思路。